Etoposide
- 1 March 1990
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 39 (3) , 438-490
- https://doi.org/10.2165/00003495-199039030-00008
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- A comparison of cis-platinum-Vindesine and cis-platinum-Etoposide combined with radiotherapy for previously untreated localized inoperable non-small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- Clinical pharmacology of high-dose etoposide associated with cisplatin. Pharmacokinetic and metabolic studiesEuropean Journal of Cancer and Clinical Oncology, 1987
- Unchanged pharmacokinetics of VP-16-213 (etoposide, NSC 141540) during concomitant administration of doxorubicin and cyclophosphamideEuropean Journal of Cancer and Clinical Oncology, 1987
- Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or EtoposideNew England Journal of Medicine, 1987
- Treatment of persistent or relapsing advanced germ cell neoplasms with cisplatin, etoposide and bleomycinEuropean Journal of Cancer and Clinical Oncology, 1986
- High-dose cisplatin and VP-16 with bleomycin, in the management of advanced metastatic germ cell tumorsEuropean Journal of Cancer and Clinical Oncology, 1986
- Etoposide (VP-16–213)New England Journal of Medicine, 1985
- Antimetastasis effect of two derivatives of epipodophyllotoxin in micePublished by Elsevier ,1976
- Combination chemotherapy with 4′Demethylepipodophyllotoxin 9-(4,6-0-ethylidene-β-d-glucopyranoside), VP 16–213 (NSC 141540) in L1210 LeukemiaPublished by Elsevier ,1976
- Response of L1210 to combinations of cytosine arabinoside and VM-26 or VP16-213Published by Elsevier ,1975